FERROUS CITRATE FE 59
LOE Approachingferrous citrate, fe-59
NDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 6d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Ferrous Citrate FE-59 is a radioactive iron-59 labeled diagnostic agent administered by injection to assess iron metabolism and red blood cell function. It is used as a diagnostic tracer to measure iron absorption, iron turnover, and hemoglobin synthesis in patients with suspected iron metabolism disorders or anemia.
LOE Approaching
This diagnostic agent faces moderate competitive pressure (30% intensity) with minimal linked job opportunities, indicating a niche specialty market with limited commercial expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Ferrous Citrate FE-59 offers minimal career growth opportunities with zero linked job openings, reflecting its niche diagnostic status and approaching loss of exclusivity. This role suits specialists seeking stable, specialized expertise in legacy radiopharmaceutical management rather than career advancement or market expansion.
Diagnostic Radiopharmaceutical Specialist
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.